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The use of gelatinase expression in dermal fibroblast cul-
tures as a marker for generalized epidermolysis bullosa sim-
plex (D-EBS-Kobner) has been tested. None of the 6 Kob-
ner patients tested (from 3 families) produced reduced 
amounts of gelatinase compared with their healthy relatives 
T he hereditary and acquired forms of the disease epi-dermolysis bullosa (EB) can be separated into at least 16 clinical and genetic types, with the dominant EB simplex as the most common form [1]. Dominant EB simplex (D-EBS) is electron microscopically char-
acterized by cytolysis of the subnuclear cytoplasm in the basal 
epidermal cells [2,3]. In spite of its epidermal localization, studies 
of dermal fibroblasts have revealed unexpected results. In a Fin-
nish family with generalized D-EBS-Kobner (D-EBS-K), a de-
crease in galactosylhydroxylysyl glucosyltransferase production 
in dermal skin fibroblasts was reported to be associated with the 
disease [4] . In another study dermal skin fibroblasts from 3 pa-
tients with D-EBS-K and 6 of 13 patients with the localized D-
EBS Weber-Cockayne (D-EBS-WC) produced extremely small 
amounts of gelatinase [5]. This trait was suggested to be a marker 
for the D-EBS-K form of the disease. If confirmed, this would 
have important implications for the development of a prenatal 
diagnosis test for severely affected families. 
The purpose of the present study was to test fibroblasts from 
EB fam ilies previously characterized by Gedde-Dah l and Anton-
Lamprecht [6,7] to determine w hether a decrease in gelatinase is; 
(1) a uniform marker for D-EBS-K: (2) associated to D-EBS-K 
in some families because of genetic heterogeneity or because of 
close genetic linkage between the D-EBS gene locus on· the one 
hand and a structural or regulatory gelatinase gene locus on the 
other hand; or (3) an accidental event. 
MA TERIALS AND METHODS 
Materials Bovine serum albumin (BSA), acid-soluble calf skin 
collagen, NAD, NADH, 4-methylumbelliferylacetate, 4-meth-
ylumbelliferone, d,l-Iactate, Coomassie Brilliant Blue G-250, 
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Abbreviations: 
BSA: bovine serum albumin 
D-EBS-K: dominant epidermolysis bullosa simplex Kobner 
(generalized) 
D-EBS-WC: dominant epidermolysis bullosa simplex Weber-
Cockayne (localized) 
EB: epidermolysis bullosa 
EsD: esterase 0 
LDH: lactic dehydrogenase 
SBTI: soybean trypsin inhibitor 
and other control groups. This shows that a reduced pro-
duction of gelatinase from dermal fibroblasts is not uni-
formly a marker for D-EBS-K. ] Invest Dermatol 87: 
326- 329, 1986 
trypsin, and soybean trypsin inhibitor (SBTI) were from Sigma. 
Culture media and fetal calf serum were from Flow Laboratories 
and GIBCO. Ready Solv HP was from Beckman and tritiated 
sodium borohydride was from Amersham. 
Subjects Skin fibroblast cultures were established from normal 
volunteers, "clinically unaffected" skin of patients with EB, and 
unaffected fam il y members of EB patients (Table I, Fig 1). Three 
independent mutations to D-EBS-K are included. They span the 
quantitative interfamilial variation seen between different Kobner 
families. The EB22-patients are among the worst regarding per-
sistent generalized blister liability (family XXII in [6]), while 
EB70-1 and EB87-1 had only moderate general blistering in in-
fancy, with the later hand and foot blistering being more marked 
than seen in the local D-EBS-WC form of the disease. All de-
veloped blisters within the first week of life. 
Fibroblast Cultures Cells from the established skin fibroblast 
cu ltures (some stored frozen) were subcultivated at passages 3-6 
in disposable plastic culture dishes or flasks in 1 X Eagle's min-
imum essential (EME) medium (modified) with Earl's salt and 
2.00 g/liter NaHC03 without glutamine, to which the following 
compounds were added (final concentrations in parentheses); fetal 
calf serum (15%), Hepes buffer pH 7.2-7.4 (5 mM), penicillin 
(100 IU/ml), streptomycin (100 p.g/ml) , nonessential amino acids 
(100 times dilution), and L-glutamine (2.00 mM) at 37°C in a 5% 
CO2 atmosphere [10]. 
To determine gelatinase expression, each culture at a density 
of 4 x 103 cells/ cm2 was seeded in 3 T -75 flasks with serum-
conta ining medium. At early confluence the cells were washed 
3-4 times with Hanks' balanced salt solution and then 6 ml serum-
free EME medium was added. After 24-h incubation the serum-
free medium was haves ted. One part was stored intact and used 
to determine the amount of extracellular protein. The other part 
was made 0.2% (w/v) in BSA/50 mM in Tris-HCl (pH 7.5) and 
stored at - 20°C before use in the gelatinase assay. The cell layers 
from these flasks were trypsinated, washed in saline, and the cell 
pellets obtained after centrifugation (600 g X 5 min) were stored 
at - 20°C. These fibroblast pellets were diluted 1: 4 with saline, 
sonicated, centrifuged at 14,000 g for 5 min at 4°C, and the su-
pernatants obtained were used in the determination of lactic de-
hydrogenase (LDH) and esterase D (EsD) activities. Saline was 
added to 10-pJ aliquots of these supernatants to give a final di-
lution of 1: 99. This was used in the determination of the amount 
of total intracellular protein. 
Gelatinolytic Activity Acid-soluble calf skin collagen was la-
beled with tritium by reductive methylation of the amino groups 
[11-13] to give labeled batches wi th specific radioactivities rang-
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Table I. Fibroblas t Strains 
Diagnosis/Code 







D-EB Herpetiformis Dowling-Meara 
EB1-1 
Recessive junctional EB; R-EB Atrophicans Gravis Herlitz 
SEB4-1 
R-EB progressiva (late onset) 
EB57-1 00 





Six health y members of D-EB fa milies and 3 other controls. 
'Fig 1 in Appendi x of [6J. 














ing from 7 to 80 p.Ci / mg collagen. The gelatin substrate was 
prepared by first mixing 1 part of the tritium-labeled collagen (1 
mg/ m1 and 30 p.Ci/mg) with 10 parts of unlabeled calf skin col-
lagen (5 mg/ml 0.01 M acetic acid). Two parts of this collagen 
mixture (0.46% w /v) were added to 2.3 parts of 0.108 M Tris-
HCI, pH 7.7, and heated at 60°C for 30 min giving a gelatin 
solution of 0.213% (w/v). 
The gelatin- degrading enzym e(s) is/a re exreted into the culture 
medium in a latent form and require(s) proteolytic activation. 
This was achieved as follows: aliquots of 0-100 p.1 of the crude 
culture medium were mixed with 0-100 p.l of serum-free EME 
medium (contianing 0.2% p.l to which 8 p.1 trypsin (2.5 mg/ ml) 
was added. This mixture was incubated for 0-2 h at 35°C and 
the activation was terminated with 5 p.1 of SBTl (50 mg/ ml) . 
After 15-min incubation at room temperature, 50 p.l of assay 
buffer (50 mM Tris-HCl pH 7.5, 0.852 M NaCl, 21.3 mM CaCl2, 
and 0.852% BSA) and 50 p.l of the 0.213% 3H-labeled gelatin 
solution (1.065 nmol based on a molecular weight of 100,000/0'-
chain) were added. The gelatinase assay was carried out at 35°C 
for approximately 20 h. The reaction was terminated by adding 
106 p.l 45% trichloracetic acid to give final concentration of15% 
[1 4]. After cooling on ice for 30 min, the assay tubes w ere cen-
trifuged for 4 min usin g a Beckman Microfuge B. Then 160 p.l 
of the supernatant was added to 5 ml Ready Solv HP and counted 
in a liquid scintillation spectrometer. The gelatinase activity ob-
tained at optimal activation (Fig. 2a) always resulted in 10-20% 
degradation of the gelatin substrate. The assay is linear up to at 
12 
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Figure 1. Pedigree of the D-EBS-K family EB22 (XXI! in [6]). Gelatin 
degrading activity in nmollh/mg protein (mean ::+:: SD) is given under 
the symbols: unaffected (striped box)/affected (so lid box ) male; unaffected 






































least 30% degradation of the gelatine substrate as shown in Fig. 
2b. 
Other Assays The initial rate m easurements to determine the 
activity of LDH and EsD were carried out on a recording filter 
fluorim eter, using an excitation wavelength of 328 nm and an 
emission wavelength of 460 nm. The LDH assay was carried out 
with fixed concentrations of 1 mM NAD and lmM d,l-Iactate 
in a total volume of3 ml 0.1 M glycine-NaOH buffer pH 10.0 
at 23 .5°C [15,16]. The assay for EsD contained 0.1 mM 4-meth-
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Figure 2. Gelatin degrading activity of crude culture medium from fi-
broblasts of a patient with D-EBS-K (EB22-1 ). Fifty J.Ll of crude culture 
medium (1.49 J.Lg protein) were proteolytically activated with 20 J.Lg tryp-
sin for either 0-2 h (a) or 1 h (b) at 35°C. All mixtures were assayed for 
gela tinase activity as described in Materials a/'ld Methods. The amount of 
gela tin degraded at maximum gelatinase activation was always calculated 
from 100% trypsin diges tion of the gelatin substrate (66,000 ::+:: 1,000 
dpm). All assays were done at least in triplica te, with each point repre-
senting mean ± SD. a, Proteolytic activation curve. After preactivation 
all mixtures were assayed for 21 .5 h at 35°C. h, Time dependence curve 
of gela tin degradation; ope/'l circle, unactivated crude culture medium; solid 
circle, proteolytically activated crude culture medium. 
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Table II. Gelatinolytic Protease, Lactic Dehydrogenase, and Esterase D Acti vities in Fibroblast C ultures 
Gelatinase Acti vity 
Es D Activity LDH activity 
Number of nmol/h/ l 06 nmollh/mg (nmoll min/mg (n mollmin/mg 
Culture Cultures nl11ol/h/T-75 cell" protein/' protein'l cuvette) protein'/cllve tte) 
Genera lized 
D-EBS-K (N = 6) 8 0.82 :t 0.07 0.21 :t 0.02 4.5 :t 0.5 18 :t 4 253 :t 28 
Controls (N = 3) 
(EBS relatives) 3 0.81 :t 0. 12 0.22 :t 0.04 3.8 :t 0.3 17 :t 4 193 :t 50 
Controls (N = 6) 
(non-EBS) 12 0.89 :t 0.06 0.20 :t 0.01 6.3 :t 0.6 18 :t 3 199 :t 27 
Other EB (N = 6) 7 0.92 :t 0.09 0.28 :t 0.03 4.2 :t 0.6 22 :t 2 274 :t 20 
"The nu mber of cel ls per T-75 Aask we re cou nted on a Cou lter Counter. 
'A mount of extracellu la r protein . 
(A mount of in tracel lular protein . 
acetate buffer pH 5.5 at 23. 5°C [1 7]. T he reactions were started 
by the addition of 10 IlJ of sonicated cell solution. T he amount 
of product produ ced was calculated fro m standard curves ob-
tained with pure products (NADH and 4-meth ylumbelli fe rone). 
To determine the amount of extra- and intracellular protein , 
the CBB G-250 dye method of Sedmak and Grossberg (1 8] was 
used . Standard curves were obtained w ith 0- 2 p,g BSA. 
RESU LTS 
In this study of the expression of gelatinolytic activity in fibrobl as t 
cultures, optimal conditions as described by Sanchez et al [5] have 
been used . T he integrity of the fib roblas t cultures was tested by 
measuring the ac tivity level of the 2 cytoplasmatic enzymes LDH 
and EsD. N o significant differences between the cell cultures were 
found (Table II). J;, ikewise, the amount of extracellular protein 
expressed in micrograms per T -75 flask varied within a range 
compatible with normal in vitro cell function . N o systematic 
di ffe rence between the D -EBS-K patients (1 70 ± 20) and their 
unaffec ted relatives (209 ± 23), o ther EB patients (270 ± 46) or 
unrelated controls (1 53 ± 19) (mean :t SE) was found . 
In Table II the gelat inase activi ty per hour is depicted in 3 
different ways: per fl as k, per cell count, and per mi ll igrams pro-
tein in th e crude medium. Whereas all groups of subj ects gave 
similar results using the first 2 ways, there was some va riation 
w hen the activity was expressed per millig rams proteili in the 
crude medium. N o individual w ith g rossly reduced gelatinase 
activity was found. T he average of the cu ltu res for the D -EBS-
K patients is similar to the enzyme activity for other EB patients. 
They are insignifi ca ntly higher than fo r the unaffected relatives, 
ye t somewhat below the values fo r the geneticall y unrel ated con-
trols. Fig 1 illustra tes the indi vidual va riation within the EB22 
fa mily. Although on the w hole below average for all the samples 
tested, redu ced gelatinase activity is clea rly demonstrated un as-
sociated with the presence of the D-EBS-K gene in this fa mil y. 
DISC USSIO N 
Dominant EB simplex can clinicall y and genetica ll y be divided 
in to at least 4 ty pes: D-EBS-K (generalized), D-EBS-WC (10-
calized), D-EBS Ogna (mild w ith fragile skin) , and D-EBS mot-
tled pigmentation (generalized) [1 ,19]. As these diseases are poorly 
characterized with respect to biochemi cal traits, genetic hetero-
geneity can be in ves tigated if geneti c linkage to a geneti c marker 
system is demonstrated, i.e., a gene located beside the EB gene 
on the chromosome. A close genetic linkage to o ther genes en-
ables us to distinguish between clinically and electron micro-
scopically similar d iseases. D-EBS Ogna has been distin guished 
as a separate geneti c entity as it, in contras t to the o ther simplex 
fo rms, is closely linked to the GPT locus (on ch romosome 8 o r 
16) [20,21] . However, D-EBS-K 'o r D-EBS-WC genes have so 
far no confirmed assignment to a linkage group or specified chro-
mosome. 
T he decrease in gelatinase activity in patients with D-EBS-K 
has been suggested to be a ma rker and hence a diagnostic tool 
for the Kobner fo rm of the disease [5] . A sim ilar defect in 6 o f 
13 D-EBS-WC patients indicated that some of the D-EBS-WC 
mutations could belong to the sa me gene locus as D-EBS-K [5] . 
In contras t to this, no decrease in gelatin ase ac tivity was found 
in any of our 6 D-EBS-K patients tes ted (representin g 3 muta-
tions) compared with controls. T his excludes a defect in the ge-
latin ase expression in fib roblas t cultures being uniformly a m arker 
fo r the D-EBS-K fo rm of the disease. Since bo th studies used 
comparable, though slightl y diffe rent methods fo r gelatinase 
expression, these results could be interpreted as genetic hetero-
geneity in th e D-EBS-K group such as Sanchez et al [5] sugges ted 
fo r the D-EBS-WC group . However, in the absence o f a parallel 
clinical heterogeneity, another possibility is that th e gene locus 
fo r D-EBS could be immediately adj acent to the gene locus for 
gela tinase or a gene that regul ates the gelatinase expression . So m e 
mu ta tions may therefore delete o r in volve expression of bo th loci 
and o thers only D-EBS. A predi ction fro lll this hypothesis is the 
existence of gelatin ase Illu ta ti ons leaving the D-EBS locus intac t . 
It is important to stress th at the gelatin ase defi ciency tra it is 
no t yet proven to be dominantl y inherited, and its frequency in 
the general population is no t well es tablished. If present in EBS 
only by coincidence so that the materi als are no t selected w ith 
rega rd to gelat inase defi ciency, the freq uency in N orway should 
be less than 1116 unrelated persons and in the United States pop-
ulati on in the range 0/22 + 3/3 + 6/13? = 9/38. I t would there-
fo re be most pro fitable to study the United States fa milies and 
population . We are currentl y proceeding with the study of N or-
wegian D-EBS-WC patients and families. From the unusually 
high mutation rate of 1.6/million gametes/generation of the pooled 
D-EBS-K and -WC genes [7] , we acknowledge the possibility of 
more than one gene locus fo r these mutations. 
The EBS-gelatinase puzzle is di ffe rent fro m that related to the 
galac tosylhydroxylysyl glucosyltransferase defi ciency in the sin-
gle Finnish fa mil y where 1 or 2 D-EBS patients were enzym o-
logicall y normal and 2 non-EBS patients had the enzy me defi-
ciency [4] . Rather than interpreting this as the effect of a single 
unusual mutant gene, which requires assumptions regarding non-
penetrance of a gene for generalized EBS [4], we consider loose 
genetic linkage the best interpretation vs chance coseg regation of 
2 rare traits. T he fa mily gives maximum linkage (Iod) score of 
+ 1.10 at a map distance of 18% recombination between the 2 
disease loci, whereas + 3 (i. e., odds for linkage 1000: 1) is required 
to prove linkage. 
T he recent observa tion of Fine and Griffith [22] that all of 6 
D-EBS-WC and 2 D-EBS-K patients had epidermal cells w ith 
an abnormal binding of peanut agglutinin , suggested a specific 
defect in glycosylation and therefore a new direction of EBS 
research. 
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